PRODUCELL
DEAD

Serial Number

78227284

Owner

Thromb-X NV

Filing Date

Mar 19, 2003

Add to watchlist:

No watchlists yet
View on USPTO

PRODUCELL Trademark

Serial Number: 78227284

PRODUCELL is a trademark filed by Thromb-X NV on March 19, 2003. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 40 (Treatment & Processing), Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

Thromb-X NV (7 trademarks)

Groot Begijnhof
Leuven, Vlaams Brabant B-3000 , BE

Entity Type: 03

Trademark Details

Filing Date

March 19, 2003

Registration Date

Not Registered

Published for Opposition

January 27, 2004

Goods & Services

Custom manufacture of reagents for others, namely, customized synthesis of biological matter

Pre-mixed, pre-dispensed reagents, namely, nucleotides and nucleotide preparations, ionic salts, buffer, and stabilizing reagents, or a combination thereof, for performing, polymerase chain reaction, DNA profiling experiments and random amplified polymorphic DNA analysis detection, labeling and or sequencing of DNA; pre-mixed, pre-dispensed reagents, namely, a lambda packaging kit primarily comprised of nucleotides and nucleotide preparations for in vitro packaging and planting of CDNA and biochemicals, namely, sets of cloned DNA fragments that together represent the entire genome, to the genes transcribed by a particular tissue cloned into bacteriophage lambda DNA; pre-mixed, pre-dispensed reagents, namely, vectors for the general cloning, sequencing and expression of foreign genes; pre-mixed, pre-dispensed reagents, namely, polynucleotide kinase for use in the detection labeling and or sequencing of DNA or RNA and chemical reagents for use therewith; and pre-mixed, pre-dispensed reagents, namely, DNA ligase for covalently joining DNA fragments; all for medical or clinical laboratory use; manipulating and expressing recombinant DNA for medical use; chemical, biochemical, biological and biotechnological preparations and substances, namely, recombinant vectors for medical use in laboratories, diagnostics and analytics

Chemical, biochemical, biological and biotechnological preparations and substances for scientific and medical research use, namely, recombinant vectors for cloning; proteins and reagents for scientific and medical research use, namely, for use in recombinant protein expression purification; manipulating and expressing recombinant DNA for industrial, scientific, and medical research use; chemical, biochemical, biological and biotechnological preparations and substances, namely, recombinant vectors for industrial, scientific, and medical research use in laboratories, diagnostics and analytics; chemical, biochemical, biological and biotechnological preparations and substances, namely, cell growth support structures and substrates for use in cell cultures for industrial, scientific and medical research; chemical, biochemical, biological and biotechnological preparations and substances for use in the manufacture of medicines, pharmaceuticals, diagnostics, vaccines, antibodies and biological molecules; synthetic resins, preparations and substances for use in the manufacture of medicines, pharmaceuticals, diagnostics, vaccines, antibodies and biological molecules; and auxiliary preparations, carriers and substances for use in the manufacture of medicines, pharmaceuticals, diagnostics, vaccines, antibodies and biological molecules

Provision of molecular biology services, namely, recombinant DNA cloning, nucleic acid isolation and analysis, and consultation services for design and execution of molecular biology experiments; medical and scientific research and product development services for others; chemical analysis in the field of biochemistry; laboratory research in the field of biotechnology; conducting screening assays for drug development; biological cloning services; chemical analysis; diagnostic services in the field of recombinant production; development of new technology for the others in the field of recombinant biotechnology; product research and development, scientific research; technical consultation in the field of biotechnology; product research and development; scientific research; technical consultation in the field of biotechnology and in the field of recombinant production technology

Filing History

ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Dec 10, 2007 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Dec 6, 2007 ABN6
NOA MAILED - SOU REQUIRED FROM APPLICANT
Dec 26, 2006 NOAM
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Nov 1, 2006 ETOP
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Mar 8, 2005 TCCA
EXTENSION OF TIME TO OPPOSE RECEIVED
Feb 20, 2004 ETOF
PUBLISHED FOR OPPOSITION
Jan 27, 2004 PUBO
NOTICE OF PUBLICATION
Jan 7, 2004 NPUB
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 1, 2003 CNSA
EMAIL RECEIVED
Nov 3, 2003 EMRV
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 31, 2003 CRFA
NON-FINAL ACTION MAILED
Sep 15, 2003 CNRT
ASSIGNED TO EXAMINER
Sep 11, 2003 DOCK